Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION - Share options (Details)

v3.24.1.1.u2
SHARE-BASED COMPENSATION - Share options (Details)
 3 Months Ended 12 Months Ended
Mar. 31, 2024
CAD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
$ / shares
shares
Number of Share Options          
Outstanding at the beginning 898,262 898,262      
Outstanding at the end 1,152,597 1,152,597 898,262 898,262  
Weighted Average Exercise Price Per Share          
Outstanding at the beginning (in dollars per share) | $ / shares $ 7.58        
Expired (in dollars per share) | $ / shares 18.30        
Outstanding at the end (in dollars per share) | $ / shares 7.40   $ 7.58    
Vested and exercisable at the end (in dollars per share) | $ / shares $ 7.29        
Weighted Average Remaining Contractual Term (years) and Aggregate Intrinsic Value          
Fair value of options in a share based payment arrangement | $     $ 442,002 $ 442,002 $ 716,969
Decrease in fair value | $   $ 294,967      
CAD          
Number of Share Options          
Outstanding at the beginning 898,262 898,262      
Expired (14,665) (14,665)      
Granted 0 0      
Outstanding at the end 883,597 883,597 898,262 898,262  
Vested and exercisable at the end 793,570       793,570
Weighted Average Remaining Contractual Term (years) and Aggregate Intrinsic Value          
Outstanding at the beginning (in years) 6 years 4 months 24 days 6 years 4 months 24 days 6 years 6 months 6 years 6 months  
Outstanding at the end (in years) 6 years 4 months 24 days 6 years 4 months 24 days 6 years 6 months 6 years 6 months  
Vested and exercisable at the end (in years) 6 years 4 months 24 days 6 years 4 months 24 days      
Outstanding at the end (in dollars) | $ $ 27,581        
Vested and exercisable at the end (in dollars) | $ $ 27,581        
Granted 0 0      
Number of options exercised 0 0      
USD          
Number of Share Options          
Outstanding at the beginning 69,000 69,000      
Granted 200,000 200,000      
Outstanding at the end 269,000 269,000 69,000 69,000  
Vested and exercisable at the end 58,333       58,333
Weighted Average Exercise Price Per Share          
Outstanding at the beginning (in dollars per share) | $ / shares   $ 1.87      
Granted (in dollars per share) | $ / shares   1.17      
Outstanding at the end (in dollars per share) | $ / shares   $ 1.35   $ 1.87  
Vested and exercisable at the end (in dollars per share) | $ / shares         $ 1.17
Weighted Average Remaining Contractual Term (years) and Aggregate Intrinsic Value          
Outstanding at the beginning (in years) 9 years 8 months 12 days 9 years 8 months 12 days      
Outstanding at the end (in years) 9 years 8 months 12 days 9 years 8 months 12 days      
Vested and exercisable at the end (in years) 9 years 8 months 12 days 9 years 8 months 12 days      
Granted | $   $ 44,000      
Outstanding at the end (in dollars) | $   $ 150,760      
Vested and exercisable at the end (in dollars) | $         $ 43,166
Granted 200,000 200,000      
Number of options exercised 0 0      
Grant date fair value of share options granted | $   $ 182,820